DK3216784T3 - Fremgangsmåde til fremstilling af histamin-h3-receptor-modulatorer - Google Patents

Fremgangsmåde til fremstilling af histamin-h3-receptor-modulatorer Download PDF

Info

Publication number
DK3216784T3
DK3216784T3 DK17151754.3T DK17151754T DK3216784T3 DK 3216784 T3 DK3216784 T3 DK 3216784T3 DK 17151754 T DK17151754 T DK 17151754T DK 3216784 T3 DK3216784 T3 DK 3216784T3
Authority
DK
Denmark
Prior art keywords
compound
formula
group
range
molar equivalents
Prior art date
Application number
DK17151754.3T
Other languages
English (en)
Inventor
Diego Broggini
Vit Lellek
Neelakandha S Mani
Susanne Lochner
Adrian Mauer
Daniel J Pippel
Lana Young
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK3216784T3 publication Critical patent/DK3216784T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)

Claims (6)

1. Fremgangsmåde til fremstilling afen forbindelse med formel (l-E)
hvori R1 er valgt fra gruppen, der består af Ci-4-alkyl og C3-io-cycloalkyl; m er 2; R2 er valgt fra gruppen, der består af -OCHR3R4 og -Z-Ar; R3 er hydrogen og R4 er en C3-io-cycloalkyl eller heterocycloalkylring; hvor C3-io-cycloalkyl eller heterocycloalkylringen er usubstitueret eller substitueret med -Ci-4-alkyl eller acetyl; alternativt, danner R3 og R4 sammen med det carbon, hvortil de er bundet, en C3-io-cycloalkyl eller heterocycloalkylring; hvor C3-io-cycloalkyl eller heterocycloalkylringen er usubstitueret eller substitueret med -C1-4-alkyl eller acetyl; Z er valgt fra gruppen, der består af S og O; Ar er en phenyl eller heteroaryl; hvor phenyl eller heteroarylen er usubstitueret eller substitueret med en, to eller tre R5-substituenter; hvor hver R5-substituent er uafhængigt valgt fra gruppen, der består af halogen, -Ci-4-alkyl, -OH, -OCi-4-alkyl, -SCi-4-alkyl, -CN, -CONRaRb, og -NO2; og hvor Ra og Rb er hver uafhængigt -H eller -Ci-4-alkyl; eller et farmaceutisk acceptabelt salt, et farmaceutisk acceptabelt prodrug deraf, hvor "prodrug" refererer til forbindelser med en aminosyre-rest eller en polypeptidkæde af to eller flere aminosyrerester, der er covalent forbundet gennem en amid- eller esterbinding til en fri amino-, hy-
droxyl- eller carboxylsyregruppe af en forbindelse med formel (l-E); forbindelser der er fremstillet ved derivatisering af frie hydroxylgrupper ved anvendelse af grupper, der indbefatter hemisuccinater, phosphatestere, dimethylaminoacetaterog phosphoryloxymethyloxycarbonyler; carba-matderivater af hydroxyl- og aminogrupper; carbonatderivater, sulfonate-stere og sulfatestere af hydroxylgrupper; forbindelser der er fremstillet ved derivatisering af hydroxylgrupper som (acyloxy)methyl- og (acyloxy)ethylethere, hvor acylgruppen kan være en alkylester, der eventuelt er substitueret med en eller flere ether-, amin- eller carboxylsyre-funktionaliteter, eller hvor acylgruppen er en aminosyreester og forbindelser der er fremstillet ved derivatisering af frie aminer som amider, sulfonamider eller phosphonamider; hvilken fremgangsmåde omfatter:
at omsætte en forbindelse med formel (V-S) med et aldehyd- eller ketonderivat af den ønskede R1-substituentgruppe; pur eller i et organisk opløsningsmiddel for at opnå den tilsvarende forbindelse med formel (IX);
at omsætte forbindelsen med formel (IX) med en forbindelse med formel (VI), hvor LG1 er en første leavinggruppe og LG2 er en leavinggruppe; i nærvær af et reduktionsmiddel; i et organisk opløsningsmiddel; til at opnå den tilsvarende forbindelse med formel (X-E);
at omsætte forbindelsen med formel (X-E) med en forbindelse med formel (XII); i nærvær af en første uorganisk base; i et organisk opløsningsmiddel; eller at omsætte forbindelsen med formel (X-E) med en forbindelse med formel (XIII); i nærvær af en anden uorganisk base; i et organisk opløsningsmiddel; for at give den tilsvarende forbindelse med formel (l-E).
2. Fremgangsmåden ifølge krav 1, hvor R1 er cyclobutyl, m er 2 og R2 er valgt fra gruppen, der består af 4-fluorphenyl, 3-cyanophenyl, 4-tetrahydropyranyl, LG1 er chlor og LG2 er chlor.
3. Fremgangsmåden ifølge krav 1, hvor R1 er cyclobutyl.
4. Fremgangsmåden ifølge krav 1, hvor R2 er -OCHR3R4, og R3 og R4 sammen med det carbon, hvortil de er bundet, danner tetrahydropyranyl, eller hvor R2 er -Z-Ar og Ar er valgt fra gruppen, der består af 3-cyanophenyl eller 4-fluorphenyl.
5. Fremgangsmåden ifølge krav 1, hvor LG1 er chlor og LG2 er chlor.
6. Fremgangsmåden ifølge krav 1 til fremstilling af en forbindelse med formlen (l-E) eller et farmaceutisk acceptabelt salt deraf.
DK17151754.3T 2009-03-18 2010-03-17 Fremgangsmåde til fremstilling af histamin-h3-receptor-modulatorer DK3216784T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16117709P 2009-03-18 2009-03-18
EP10722449.5A EP2429996B1 (en) 2009-03-18 2010-03-17 Process for the preparation of histamine h3 receptor modulators

Publications (1)

Publication Number Publication Date
DK3216784T3 true DK3216784T3 (da) 2019-04-08

Family

ID=42315639

Family Applications (2)

Application Number Title Priority Date Filing Date
DK17151754.3T DK3216784T3 (da) 2009-03-18 2010-03-17 Fremgangsmåde til fremstilling af histamin-h3-receptor-modulatorer
DK10722449.5T DK2429996T3 (en) 2009-03-18 2010-03-17 Process for the preparation of histamine h3 receptor modulators

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK10722449.5T DK2429996T3 (en) 2009-03-18 2010-03-17 Process for the preparation of histamine h3 receptor modulators

Country Status (18)

Country Link
US (4) US8748596B2 (da)
EP (3) EP3216784B1 (da)
JP (1) JP5642149B2 (da)
CN (1) CN102428070B (da)
AU (1) AU2010226711B2 (da)
CA (2) CA2755335C (da)
CY (2) CY1119437T1 (da)
DK (2) DK3216784T3 (da)
ES (2) ES2625261T3 (da)
HR (2) HRP20170776T1 (da)
HU (2) HUE044837T2 (da)
LT (2) LT2429996T (da)
MX (3) MX347775B (da)
PL (2) PL3216784T3 (da)
PT (2) PT3216784T (da)
SI (2) SI2429996T1 (da)
TR (1) TR201902858T4 (da)
WO (1) WO2010107897A2 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8748596B2 (en) 2009-03-18 2014-06-10 Janssen Pharmaceutica Nv Process for the preparation of histamine H3 receptor modulators
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
CN104447867B (zh) * 2013-09-17 2017-12-26 江苏天士力帝益药业有限公司 一种噻吩并哌啶衍生物、制备方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5724346B2 (da) * 1973-06-22 1982-05-24
NZ576432A (en) * 2002-10-23 2010-06-25 Janssen Pharmaceutica Nv Piperazinyl and diazapanyl benzamides and benzthioamides
AU2007256931B2 (en) 2006-05-30 2013-01-24 Janssen Pharmaceutica N.V. Substituted pyridyl amide compounds as modulators of the histamine H3 receptor
KR101546712B1 (ko) * 2007-11-20 2015-08-24 얀센 파마슈티카 엔.브이. 히스타민 h3 수용체의 조절제로서 사이클로알킬옥시- 및 헤테로사이클로알킬옥시피리딘 화합물
US8748596B2 (en) 2009-03-18 2014-06-10 Janssen Pharmaceutica Nv Process for the preparation of histamine H3 receptor modulators

Also Published As

Publication number Publication date
HUE044837T2 (hu) 2019-11-28
MX2011009784A (es) 2011-09-30
US20140343279A1 (en) 2014-11-20
SI2429996T1 (sl) 2017-08-31
EP3492451A2 (en) 2019-06-05
AU2010226711B2 (en) 2015-06-18
MX349489B (es) 2017-07-31
CA2755335A1 (en) 2010-09-23
EP3492451B1 (en) 2021-11-03
CA2965059C (en) 2020-04-28
PL3216784T3 (pl) 2019-07-31
JP2012520889A (ja) 2012-09-10
PL2429996T3 (pl) 2017-08-31
EP3216784A1 (en) 2017-09-13
EP3492451A3 (en) 2019-07-31
US10323002B2 (en) 2019-06-18
DK2429996T3 (en) 2017-06-19
EP2429996A2 (en) 2012-03-21
CY1119437T1 (el) 2018-03-07
SI3216784T1 (sl) 2019-05-31
TR201902858T4 (tr) 2019-03-21
HUE032345T2 (en) 2017-09-28
US20170057919A1 (en) 2017-03-02
WO2010107897A2 (en) 2010-09-23
US20180022704A1 (en) 2018-01-25
CN102428070B (zh) 2015-05-06
CY1121556T1 (el) 2020-05-29
LT3216784T (lt) 2019-03-25
JP5642149B2 (ja) 2014-12-17
US20120029189A1 (en) 2012-02-02
PT2429996T (pt) 2017-06-12
EP2429996B1 (en) 2017-03-08
US9809547B2 (en) 2017-11-07
CA2755335C (en) 2018-09-18
HRP20170776T1 (hr) 2017-08-11
MX347775B (es) 2017-05-11
CN102428070A (zh) 2012-04-25
ES2714852T3 (es) 2019-05-30
LT2429996T (lt) 2017-06-12
HRP20190476T1 (hr) 2019-05-03
CA2965059A1 (en) 2010-09-23
PT3216784T (pt) 2019-04-01
ES2625261T3 (es) 2017-07-19
WO2010107897A3 (en) 2011-04-14
US9518021B2 (en) 2016-12-13
US8748596B2 (en) 2014-06-10
EP3216784B1 (en) 2018-12-26
AU2010226711A1 (en) 2011-10-13

Similar Documents

Publication Publication Date Title
US20080045507A1 (en) Substituted benzamide modulators of the histamine h3 receptor
US20090131417A1 (en) Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
US10323002B2 (en) Process for the preparation of histamine H3 receptor modulators
EP2222664B1 (en) Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor
WO2008109333A1 (en) Indole and benzothiophene compounds as modulators of the histamine h3 receptor
AU2015221574A1 (en) Process for the preparation of histamine H3 receptor modulators
US20090131416A1 (en) Substituted pyrazinyl amide compounds as modulators of the histamine h3 receptor